A Debeljak

420 total citations
12 papers, 277 citations indexed

About

A Debeljak is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Anesthesiology and Pain Medicine. According to data from OpenAlex, A Debeljak has authored 12 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 3 papers in Surgery and 3 papers in Anesthesiology and Pain Medicine. Recurrent topics in A Debeljak's work include Pleural and Pulmonary Diseases (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). A Debeljak is often cited by papers focused on Pleural and Pulmonary Diseases (5 papers), Lung Cancer Diagnosis and Treatment (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). A Debeljak collaborates with scholars based in Slovenia and United Kingdom. A Debeljak's co-authors include Nadja Triller, Mitja Košnik, Peter Korošec, Izidor Kern, Viljem Kovač, Izidor Kern, Martina Vrankar, T Rott, Matjaž Zwitter and Aleš Rozman and has published in prestigious journals such as European Respiratory Journal, Lung Cancer and Anti-Cancer Drugs.

In The Last Decade

A Debeljak

12 papers receiving 266 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A Debeljak Slovenia 7 141 85 78 68 65 12 277
Nobuaki Fujikuni Japan 10 127 0.9× 27 0.3× 63 0.8× 33 0.5× 134 2.1× 38 272
Yongdong Wu China 10 57 0.4× 28 0.3× 43 0.6× 74 1.1× 132 2.0× 26 267
Valentina Pinelli Italy 12 276 2.0× 36 0.4× 28 0.4× 29 0.4× 40 0.6× 24 370
Yaron Gesthalter United States 9 178 1.3× 31 0.4× 83 1.1× 65 1.0× 30 0.5× 28 292
Massimiliano Bassi Italy 8 93 0.7× 33 0.4× 35 0.4× 20 0.3× 32 0.5× 30 178
Christian Franke Germany 10 96 0.7× 42 0.5× 38 0.5× 57 0.8× 57 0.9× 21 294
Rose S. Wong United States 6 209 1.5× 45 0.5× 62 0.8× 30 0.4× 58 0.9× 9 286
Weijue Xu China 10 72 0.5× 15 0.2× 23 0.3× 57 0.8× 150 2.3× 36 255
Masato Kondo Japan 11 148 1.0× 13 0.2× 98 1.3× 50 0.7× 195 3.0× 39 326
Seika Kuroda Japan 11 145 1.0× 20 0.2× 23 0.3× 74 1.1× 209 3.2× 18 338

Countries citing papers authored by A Debeljak

Since Specialization
Citations

This map shows the geographic impact of A Debeljak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Debeljak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Debeljak more than expected).

Fields of papers citing papers by A Debeljak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Debeljak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Debeljak. The network helps show where A Debeljak may publish in the future.

Co-authorship network of co-authors of A Debeljak

This figure shows the co-authorship network connecting the top 25 collaborators of A Debeljak. A scholar is included among the top collaborators of A Debeljak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Debeljak. A Debeljak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Rozman, Aleš, A Debeljak, & Izidor Kern. (2011). Thoracoscopy, a study of 129 procedures. Slovenian Medical Journal. 80. 546–552. 2 indexed citations
2.
Kovač, Viljem, et al.. (2011). A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesothelioma. Anti-Cancer Drugs. 23(2). 230–238. 26 indexed citations
3.
Debeljak, A, et al.. (2007). Cardiac tamponade as the initial manifestation of pulmonary adenocarcinoma. Radiology and Oncology. 41(4). 3 indexed citations
4.
Debeljak, A, et al.. (2007). Talc pleurodesis: comparison of talc slurry instillation with thoracoscopic talc insufflation for malignant pleural effusions.. PubMed. 11(4). 463–7. 22 indexed citations
5.
Debeljak, A, et al.. (2006). Exploratory thoracotomy and its influence on the survival of patients with lung cancer. Wiener klinische Wochenschrift. 118(15-16). 479–484. 6 indexed citations
6.
Triller, Nadja, Peter Korošec, Izidor Kern, Mitja Košnik, & A Debeljak. (2006). Multidrug resistance in small cell lung cancer: Expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease. Lung Cancer. 54(2). 235–240. 97 indexed citations
7.
Sok, Miha, et al.. (2005). Surgical treatment of malignant pleural mesothelioma. Experience in the interdisciplinary approach in Slovenia. Radiology and Oncology. 39(2). 2 indexed citations
8.
Debeljak, A, et al.. (2005). Characterization of lung cancer patients, their actual treatment and survival: experience in Slovenia. Radiology and Oncology. 39(2). 3 indexed citations
9.
Triller, Nadja, et al.. (2004). Topical Anesthesia With Lidocaine and the Role of Atropine in Flexible Bronchoscopy. Journal of Bronchology. 11(4). 242–245. 1 indexed citations
10.
Debeljak, A, et al.. (1999). Bronchoscopic removal of foreign bodies in adults: experience with 62 patients from 1974–1998. European Respiratory Journal. 14(4). 792–792. 88 indexed citations
11.
Debeljak, A, et al.. (1994). Bronchoalveolar Lavage in the Diagnosis of Peripheral Primary and Secondary Malignant Lung Tumors. Respiration. 61(4). 226–230. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026